SAB Biotherapeutics, Inc. (SABS)
3.60
+0.03
(+0.84%)
USD |
NASDAQ |
May 29, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
SAB Biotherapeutics EPS Diluted (Quarterly) : -0.3523 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
| Anixa Biosciences, Inc. | -0.0772 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.87M |
| Total Expenses (Quarterly) | 18.87M |
| Enterprise Value | 174.05M |
| Earnings Yield | -68.51% |
| Normalized Earnings Yield | -81.83 |